ATAD2 and colorectal carcinoma: Then, we tested 300 CRC tissue samples by using the method of immunohistochemical staining and found that ATAD2 was low expressed in the 124 (41.33%) of the total 300 CRC samples while the remaining 176 (58.67%) samples remained at a high expression level (Figures 2(a)–2(c)).